Literature DB >> 17653719

Elderly-onset gout: a review.

Francesco De Leonardis1, Marcello Govoni, Matteo Colina, Marco Bruschi, Francesco Trotta.   

Abstract

Elderly-onset gout (EOG), defined as a disease with onset at age 65 years or over, shows relevant epidemiological, clinical and therapeutic differences from the typical middle-age form. The main differences are the more frequent subacute/chronic polyarticular onset with hand involvement, the unusual localization of tophi on ostheoarthritis (OA) nodes, the increased female/male ratio and the frequent association with drugs that decrease renal urate excretion (diuretics and low-dose aspirin) and/or with primitive renal impairment. EOG has recently been confirmed as the most common inflammatory arthropathy in older people, with important demographic implications and substantial impact on daily clinical practice. Despite the high prevalence, gout, in the elderly, often remains misdiagnosed or diagnosed late in its clinical course. Even when correctly recognized, its treatment is often difficult or unsatisfactory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653719     DOI: 10.1007/s00296-007-0421-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  60 in total

1.  Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide.

Authors:  C Fernández; R Noguera; J A González; E Pascual
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

2.  The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.

Authors:  A Schmidt; U Gruber; G Böhmig; E Köller; G Mayer
Journal:  Nephrol Dial Transplant       Date:  2001-05       Impact factor: 5.992

3.  Podagra is more than gout.

Authors:  J S Bomalaski; H R Schumacher
Journal:  Bull Rheum Dis       Date:  1984

4.  Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.

Authors:  J G Puig; F Mateos; A Buño; R Ortega; F Rodriguez; R Dal-Ré
Journal:  J Hypertens       Date:  1999-07       Impact factor: 4.844

5.  Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography.

Authors:  J C Gerster; M Landry; L Dufresne; J Y Meuwly
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

6.  Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Authors:  T R Mikuls; J T Farrar; W B Bilker; S Fernandes; H R Schumacher; K G Saag
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine.

Authors:  C J Roberge; M Gaudry; R de Médicis; A Lussier; P E Poubelle; P H Naccache
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Nodal osteoarthritis and gout: a report of four new cases.

Authors:  K Foldes; C A Petersilge; M H Weisman; D Resnick
Journal:  Skeletal Radiol       Date:  1996-07       Impact factor: 2.199

9.  Gout in the elderly, a separate entity?

Authors:  E J ter Borg; J J Rasker
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

10.  Diuretic-induced gout in elderly women.

Authors:  D G Macfarlane; P A Dieppe
Journal:  Br J Rheumatol       Date:  1985-05
View more
  11 in total

Review 1.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

2.  Gout in Older Adults: The Atherosclerosis Risk in Communities Study.

Authors:  Bridget Teevan Burke; Anna Köttgen; Andrew Law; Morgan Grams; Alan N Baer; Josef Coresh; Mara A McAdams-DeMarco
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-12-28       Impact factor: 6.053

3.  Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Hariklia Dimitroula; Tilemahos Sfetsios; Despina Parcharidou; Haralambos Karvounis; Loukas Settas
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

4.  Ulcerated tophaceous gout.

Authors:  Girish K Patel; Wendy L Davies; Patricia P Price; Keith G Harding
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

5.  Management of Gout and Hyperuricemia in CKD.

Authors:  Ana Beatriz Vargas-Santos; Tuhina Neogi
Journal:  Am J Kidney Dis       Date:  2017-04-26       Impact factor: 8.860

6.  Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity.

Authors:  Mukund Kumar; Natalie Manley; Ted R Mikuls
Journal:  Drugs Aging       Date:  2021-06-09       Impact factor: 3.923

Review 7.  Management of hyperuricemia in gout: focus on febuxostat.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

Review 8.  Musculoskeletal Pain in Older Adults: A Clinical Review.

Authors:  Travis P Welsh; Ailing E Yang; Una E Makris
Journal:  Med Clin North Am       Date:  2020-07-15       Impact factor: 5.456

Review 9.  Chronic hyperuricemia, uric acid deposit and cardiovascular risk.

Authors:  Davide Grassi; Livia Ferri; Giovambattista Desideri; Paolo Di Giosia; Paola Cheli; Rita Del Pinto; Giuliana Properzi; Claudio Ferri
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic.

Authors:  Bingqing Zhang; Weigang Fang; Xuejun Zeng; Yun Zhang; Ya Ma; Feng Sheng; Xinlei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.